Ron Kalfus
CFO @mdxhealth
Signup · Get unlimited contacts
WORK HISTORY
CFO @mdxhealth
Orange County, CA, US
Led the company through a successful NASDAQ IPO in 2021, securing critical capital for expansion and achieving publicly-traded status.Directed the financial strategy for the $100M acquisition of the Genomic Prostate Score (GPS) test from Exact Sciences (EXAS) in 2022 and the acquisition of Exosome Diagnostics from Bio-Techne in 2025.Managed SEC reporting and compliance for the public entity, ensuring timely and accurate disclosures and adherence to Sarbanes-Oxley (SOX) requirements.Improved financial forecasting accuracy and restructured the budgeting process to drive more efficient multi-million dollar resource allocation across departments.
EDUCATION
University of Georgia - Terry College of Business
BBA, Finance
Fairleigh Dickinson University
MS, Accounting
SKILLS
ABOUT RON KALFUS
Results-driven CFO and CPA specializing in building and scaling finance operations for publicly-traded and PE-backed companies. Successful NASDAQ IPO and $100M+ transaction history.Proven ability to lead and integrate cross-functional teams (Finance, IT, Analytics, Sales) through periods of high growth and complex transactions (M&A). Expert in improving fiscal performance, internal controls, and overall productivity.Core Expertise-Financial Expertise: SEC Reporting, S-1 Filing, Financial Modeling, Forecasting-Business Transformation: IPOs (NASDAQ), Private Equity (PE), M&A Due Diligence & Integration-Leadership: Cross-Functional Team Leadership, Multi-Million Dollar Budget Management
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.